NTRA

$414.304.98%-21.70

Nachbörslich: 414.300.00 0.00%

Natera Inc (NTRA)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$436.00

Offen:

$425.55

24-Stunden-Volumen:

2,361,733

Relatives Volumen:

1.61

Marktkapitalisierung:

$59.72B

Einnahmen:

$2.50B

Nettoeinkommen (Verlust:

-$226.32M

KGV:

EPS:

-$1.64

Netto-Cashflow:

$71.51M

1W Leistung:

+2.56%

1M Leistung:

+0.24%

6M Leistung:

+100.96%

1Y Leistung:

+114.42%

1-Tages-Spanne:

$408.32$431.26

1-Wochen-Bereich:

$400.00$436.19

52-Wochen-Spanne:

$181.00$437.41

Natera Inc Aktie (NTRA) Unternehmensprofil

Firmenname

Natera Inc

Sektor

Healthcare

Branche

Diagnostics & Research

Telefon

650-249-9090

Adresse

13011 MCCALLEN PASS, AUSTIN, CA, USA

Mitarbeiter

6,140

@nateragenetics

Nächster Verdiensttermin

2026-11-05

Neueste SEC-Einreichungen

SEC

NTRA-Diskussionen auf X

NTRA vs. TMO, DHR, A, WAT vergleichen

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NTRA Natera Inc	$414.30	$59.72B	$2.50B	-$226.32M	$71.51M	-$1.64
TMO Thermo Fisher Scientific Inc	$697.00	$257.71B	$45.20B	$6.87B	$6.75B	$18.19
DHR Danaher Corp	$232.23	$163.25B	$24.78B	$3.68B	$5.29B	$5.17
A Agilent Technologies Inc	$174.87	$49.30B	$7.23B	$1.41B	$1.09B	$4.98
WAT Waters Corp	$462.72	$45.46B	$3.77B	$449.25M	$240.68M	$7.86

Natera Inc Aktie (NTRA) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-10-23	Eingeleitet	Roth Capital	Buy
2026-09-09	Resumed	UBS	Buy
2026-09-08	Eingeleitet	Rothschild & Co Redburn	Buy
2026-06-26	Resumed	Bernstein	Outperform
2026-06-12	Resumed	RBC Capital Mkts	Outperform
2026-06-02	Resumed	Wolfe Research	Outperform
2026-04-14	Eingeleitet	William Blair	Outperform
2026-01-07	Eingeleitet	Citigroup	Buy
2025-12-02	Resumed	Morgan Stanley	Overweight
2025-10-27	Hochstufung	BNP Paribas Exane	Underperform → Neutral
2025-09-22	Resumed	Wells Fargo	Equal Weight
2025-03-13	Eingeleitet	RBC Capital Mkts	Outperform
2025-01-23	Eingeleitet	Barclays	Overweight
2024-06-03	Resumed	Jefferies	Buy
2024-04-08	Resumed	Craig Hallum	Buy
2024-02-20	Herabstufung	Raymond James	Strong Buy → Outperform
2023-12-29	Bestätigt	BTIG Research	Buy
2023-12-14	Eingeleitet	Guggenheim	Buy
2023-12-13	Eingeleitet	Wolfe Research	Outperform
2023-11-13	Hochstufung	Raymond James	Outperform → Strong Buy
2023-09-28	Eingeleitet	Bernstein	Mkt Perform
2023-07-05	Resumed	JP Morgan	Overweight
2023-05-05	Eingeleitet	UBS	Buy
2023-01-18	Hochstufung	Raymond James	Mkt Perform → Outperform
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2022-04-25	Eingeleitet	Stephens	Overweight
2022-03-08	Eingeleitet	Goldman	Buy
2022-01-06	Resumed	Piper Sandler	Overweight
2021-10-15	Resumed	Cowen	Outperform
2021-06-15	Eingeleitet	Raymond James	Mkt Perform
2021-05-25	Eingeleitet	Wells Fargo	Overweight
2021-01-28	Eingeleitet	Truist	Buy
2020-10-08	Eingeleitet	BTIG Research	Buy
2020-09-28	Eingeleitet	Morgan Stanley	Overweight
2020-09-17	Eingeleitet	SVB Leerink	Outperform
2020-06-10	Resumed	Piper Sandler	Overweight
2020-05-07	Hochstufung	JP Morgan	Neutral → Overweight
2018-10-05	Eingeleitet	JP Morgan	Neutral
2018-07-05	Bestätigt	Piper Jaffray	Overweight
2017-08-07	Bestätigt	Morgan Stanley	Overweight
2016-11-10	Bestätigt	The Benchmark Company	Buy
2016-05-23	Bestätigt	The Benchmark Company	Buy
2016-05-11	Bestätigt	The Benchmark Company	Buy
2016-04-19	Eingeleitet	The Benchmark Company	Buy
2015-09-28	Hochstufung	Wedbush	Neutral → Outperform
2015-08-14	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2015-08-04	Eingeleitet	Robert W. Baird	Outperform
2015-07-27	Eingeleitet	Morgan Stanley	Equal-Weight
2015-07-27	Eingeleitet	Piper Jaffray	Overweight
2015-07-27	Eingeleitet	Wedbush	Neutral

Finanzdaten der Natera Inc-Aktie (NTRA)

Umsatz

Nettogewinn

Free Cashflow

ENV

Natera Inc-Aktie (NTRA) Insiderhandel

RABINOWITZ DANIELOct 28 '26
SEC. AND CHIEF LEGAL OFFICER
Transaktion
Sale
Kosten
$426.34
#Aktien
968
Wert ($)
412,698
#Aktien Gesamt
168,221
Moshkevich SolomonOct 28 '26
PRESIDENT, CLINICALDIAGNOSTICS
Transaktion
Sale
Kosten
$426.34
#Aktien
1,162
Wert ($)
495,408
#Aktien Gesamt
104,742
Fesko JohnOct 28 '26
PRESIDENT, CHIEF BUS. OFFICER
Transaktion
Sale
Kosten
$426.34
#Aktien
898
Wert ($)
382,854
#Aktien Gesamt
195,578
Chapman Steven LeonardOct 28 '26
CEO AND PRESIDENT
Transaktion
Sale
Kosten
$426.34
#Aktien
3,430
Wert ($)
1,462,348
#Aktien Gesamt
91,232
Brophy Michael BurkesOct 28 '26
CHIEF FINANCIAL OFFICER
Transaktion
Sale
Kosten
$426.34
#Aktien
1,198
Wert ($)
510,756
#Aktien Gesamt
49,658
MICHAEL BROPHYOct 28 '26
Officer
Transaktion
Proposed Sale
Kosten
$410.82
#Aktien
1,178
Wert ($)
483,946
#Aktien Gesamt
0
DANIEL RABINOWITZOct 28 '26
OFFICER
Transaktion
Proposed Sale
Kosten
$410.82
#Aktien
988
Wert ($)
405,890
#Aktien Gesamt
0
JONATHAN SHEENAOct 28 '26
DIRECTOR
Transaktion
Proposed Sale
Kosten
$410.82
#Aktien
191
Wert ($)
78,467
#Aktien Gesamt
0
SOLOMON MOSHKEVICHOct 28 '26
OFFICER
Transaktion
Proposed Sale
Kosten
$410.82
#Aktien
1,185
Wert ($)
486,822
#Aktien Gesamt
0
JOHN FESKOOct 28 '26
OFFICER
Transaktion
Proposed Sale
Kosten
$410.82
#Aktien
917
Wert ($)
376,722
#Aktien Gesamt
0

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Oct 28 '26	Sale	$426.34	968	412,698	168,221
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Oct 28 '26	Sale	$426.34	1,162	495,408	104,742
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Oct 28 '26	Sale	$426.34	898	382,854	195,578
Chapman Steven Leonard	CEO AND PRESIDENT	Oct 28 '26	Sale	$426.34	3,430	1,462,348	91,232
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Oct 28 '26	Sale	$426.34	1,198	510,756	49,658
MICHAEL BROPHY	Officer	Oct 28 '26	Proposed Sale	$410.82	1,178	483,946	0
DANIEL RABINOWITZ	OFFICER	Oct 28 '26	Proposed Sale	$410.82	988	405,890	0
JONATHAN SHEENA	DIRECTOR	Oct 28 '26	Proposed Sale	$410.82	191	78,467	0
SOLOMON MOSHKEVICH	OFFICER	Oct 28 '26	Proposed Sale	$410.82	1,185	486,822	0
JOHN FESKO	OFFICER	Oct 28 '26	Proposed Sale	$410.82	917	376,722	0

Natera Inc Aktie (NTRA) Neueste Nachrichten

Oct 29, 2026

Natera president John Fesko sells $699,939 in common stock - Investing.com

Oct 29, 2026

Form 4 Natera Inc: Jonathan Sheena (Director, CO-FOUNDER) For: 27 October - Investing.com UK

Oct 29, 2026

To cover stock-vesting taxes, Natera (NTRA) president sells 2,172 shares. - Stock Titan

Oct 29, 2026

To cover vesting taxes, Natera (NTRA) CFO sells 781 shares and another 1,198. - Stock Titan

Oct 29, 2026

CareDx (CDNA) Surpasses Q3 Earnings and Revenue Estimates - Zacks Investment Research

Oct 29, 2026

Oct 28, 2026

An officer proposes selling 1,185 Natera (NTRA) shares worth $487K after stock awards vested. - Stock Titan

Oct 28, 2026

NTRA Q3 Earnings on Deck: Will Signatera Volume Growth Drive Results? - Zacks Investment Research

Oct 28, 2026

Oct 27, 2026

Natera Director Matthew Rabinowitz Files to Sell 1,697 RSU Shares Worth $687K - Kalkine Media

Oct 27, 2026

Natera Officer Daniel Rabinowitz Announces Plan to Sell 873 Shares Following RSU Vesting - Kalkine Media

Oct 27, 2026

Natera Officer John Fesko Announces Intent to Sell 771 Shares Valued at $312K - Kalkine Media

Oct 27, 2026

Which Biotech ETF Is the Better Buy: VanEck’s BBH or Invesco’s Factor-Driven PBE? - The Motley Fool

Oct 27, 2026

Oct 26, 2026

Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Zacks Investment Research

Oct 26, 2026

Oct 25, 2026

Stanley Druckenmiller Has Bet Big on This 1 Healthcare Stock. Here's Why I Disagree. - The Motley Fool

Oct 25, 2026

Oct 23, 2026

Natera Co-Founder Sheena Jonathan Disposes of 3,150 Shares Under Rule 10b5-1 Plan on October 21, 2026 - Kalkine Media

Oct 23, 2026

Oct 22, 2026

Biotech Giants vs. Emerging Innovators: Which ETF Is the Better Buy? - The Motley Fool

Oct 22, 2026

Oct 21, 2026

Natera Director Sheena Jonathan Files to Sell 9,450 Shares Valued at $3.88 Million - Kalkine Media

Oct 21, 2026

After a $7.01M September sale, a Natera (NTRA) director proposes another share sale. - Stock Titan

Oct 21, 2026

Natera Partners With TransCode to Advance Colorectal Cancer Trial - Zacks Investment Research

Oct 21, 2026

Oct 20, 2026

Form 4 Natera Inc: Jonathan Sheena (Director, CO-FOUNDER) For: 16 October - Investing.com Australia

Oct 20, 2026

Form 4 Natera Inc: Jonathan Sheena (Director, CO-FOUNDER) For: 16 October - Investing.com Nigeria

Oct 20, 2026

Form 4 Natera Inc: Jonathan Sheena (Director, CO-FOUNDER) For: 16 October - Investing.com India

Oct 20, 2026

Oct 19, 2026

Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)? - Zacks Investment Research

Oct 19, 2026

Oct 16, 2026

Form 4 Natera Inc: Matthew Rabinowitz (Director, EXECUTIVE CHAIRMAN) For: 15 October - Investing.com Nigeria

Oct 16, 2026

Form 4 Natera Inc: Matthew Rabinowitz (Director, EXECUTIVE CHAIRMAN) For: 15 October - Investing.com Canada

Oct 16, 2026

Under a preset plan, Natera (NTRA)'s chairman sells 50,000 shares; he also exercises options. - Stock Titan

Oct 16, 2026

Oct 15, 2026

Natera Director Matthew Rabinowitz Files Form 144 to Sell 50,000 Shares Valued at $19.7M - Kalkine Media

Oct 15, 2026

$19.7M in Natera (NTRA) shares is proposed for sale following three September sales. - Stock Titan

Oct 15, 2026

Saudi Arabia Non-Invasive Prenatal Testing Market 2026-2034: Executive Report | NGS Adoption and Healthcare Investment Drive 13.35% CAGR Toward US$162.16 Million - GlobeNewswire Inc.

Oct 15, 2026

Oct 14, 2026

Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Zacks Investment Research

Oct 14, 2026

Oct 12, 2026

Tempus AI Expands Strategic Collaborations to Drive Future Growth - Zacks Investment Research

Oct 12, 2026

Oct 09, 2026

Matthew Rabinowitz Donates 6,000 Natera Shares to Charity on October 7, 2026 - Kalkine Media

Oct 09, 2026

Oct 03, 2026

Natera CEO Steven Chapman sells $526k in common stock By Investing.com - Investing.com UK

Oct 03, 2026

Natera CEO Steven Chapman sells $526k in common stock - Investing.com

Oct 03, 2026

Oct 02, 2026

Natera (NTRA) clinical diagnostics president sells 3,000 shares under a trading plan. - Stock Titan

Oct 02, 2026

Oct 01, 2026

Morgan Stanley Smith Barney is broker for a proposed 1,273-share sale at Natera (NTRA). - Stock Titan

Oct 01, 2026

After five sales in three months, a Natera (NTRA) officer proposes another stock sale. - Stock Titan

Oct 01, 2026

Sep 26, 2026

Under a preset plan, two trusts sold 18,064 Natera (NTRA) shares in 12 transactions. - Stock Titan

Sep 25, 2026

Natera director Sheena’s trusts dispose of $7.0m in NTRA stock - Investing.com

Sep 25, 2026

Sep 23, 2026

Natera Director Sheena Jonathan to Offload 21,064 Shares Worth $8.16M, Form 144 Filed - Kalkine Media

Sep 23, 2026

Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDx - Zacks Investment Research

Sep 23, 2026

$8.2M stock sale planned at Natera (NASDAQ: NTRA) - Stock Titan

Sep 23, 2026

Sep 17, 2026

Natera (NASDAQ: NTRA) co-founder sells 9,150 shares under 10b5-1 plan - Stock Titan

Sep 17, 2026

Sep 16, 2026

Natera (NASDAQ: NTRA) chair unloads stock in preset plan - Stock Titan

Sep 16, 2026

Sep 15, 2026

Trust tied to Natera (NASDAQ: NTRA) eyes new stock sale after multimillion-dollar trades - Stock Titan

Sep 15, 2026

Sep 12, 2026

Understanding Momentum Shifts in (NTRA) - Stock Traders Daily

Sep 12, 2026

Did Earnings Beat Just Shift Natera (NTRA) Investment Narrative? - webull.com

Sep 12, 2026

Natera(NTRA.US) Officer Sells US$16.4 Million in Common Stock - Moomoo

Sep 12, 2026

Ähnlich wie NTRA

Natera Inc (NTRA)

Natera Inc Aktie (NTRA) Unternehmensprofil

NTRA vs. TMO, DHR, A, WAT vergleichen

Natera Inc Aktie (NTRA) Hochstufungen & Herabstufungen

Finanzdaten der Natera Inc-Aktie (NTRA)

Umsatz

Nettogewinn

Free Cashflow

ENV

Natera Inc-Aktie (NTRA) Insiderhandel

Natera Inc Aktie (NTRA) Neueste Nachrichten

Natera president John Fesko sells $699,939 in common stock - Investing.com

Form 4 Natera Inc: Jonathan Sheena (Director, CO-FOUNDER) For: 27 October - Investing.com UK

To cover stock-vesting taxes, Natera (NTRA) president sells 2,172 shares. - Stock Titan

To cover vesting taxes, Natera (NTRA) CFO sells 781 shares and another 1,198. - Stock Titan

CareDx (CDNA) Surpasses Q3 Earnings and Revenue Estimates - Zacks Investment Research

An officer proposes selling 1,185 Natera (NTRA) shares worth $487K after stock awards vested. - Stock Titan

NTRA Q3 Earnings on Deck: Will Signatera Volume Growth Drive Results? - Zacks Investment Research

Natera Director Matthew Rabinowitz Files to Sell 1,697 RSU Shares Worth $687K - Kalkine Media

Natera Officer Daniel Rabinowitz Announces Plan to Sell 873 Shares Following RSU Vesting - Kalkine Media

Natera Officer John Fesko Announces Intent to Sell 771 Shares Valued at $312K - Kalkine Media

Which Biotech ETF Is the Better Buy: VanEck’s BBH or Invesco’s Factor-Driven PBE? - The Motley Fool

Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Zacks Investment Research

Stanley Druckenmiller Has Bet Big on This 1 Healthcare Stock. Here's Why I Disagree. - The Motley Fool

Natera Co-Founder Sheena Jonathan Disposes of 3,150 Shares Under Rule 10b5-1 Plan on October 21, 2026 - Kalkine Media

Biotech Giants vs. Emerging Innovators: Which ETF Is the Better Buy? - The Motley Fool

Natera Director Sheena Jonathan Files to Sell 9,450 Shares Valued at $3.88 Million - Kalkine Media

After a $7.01M September sale, a Natera (NTRA) director proposes another share sale. - Stock Titan

Natera Partners With TransCode to Advance Colorectal Cancer Trial - Zacks Investment Research

Form 4 Natera Inc: Jonathan Sheena (Director, CO-FOUNDER) For: 16 October - Investing.com Australia

Form 4 Natera Inc: Jonathan Sheena (Director, CO-FOUNDER) For: 16 October - Investing.com Nigeria

Form 4 Natera Inc: Jonathan Sheena (Director, CO-FOUNDER) For: 16 October - Investing.com India

Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)? - Zacks Investment Research

Form 4 Natera Inc: Matthew Rabinowitz (Director, EXECUTIVE CHAIRMAN) For: 15 October - Investing.com Nigeria

Form 4 Natera Inc: Matthew Rabinowitz (Director, EXECUTIVE CHAIRMAN) For: 15 October - Investing.com Canada

Under a preset plan, Natera (NTRA)'s chairman sells 50,000 shares; he also exercises options. - Stock Titan

Natera Director Matthew Rabinowitz Files Form 144 to Sell 50,000 Shares Valued at $19.7M - Kalkine Media

$19.7M in Natera (NTRA) shares is proposed for sale following three September sales. - Stock Titan

Saudi Arabia Non-Invasive Prenatal Testing Market 2026-2034: Executive Report | NGS Adoption and Healthcare Investment Drive 13.35% CAGR Toward US$162.16 Million - GlobeNewswire Inc.

Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Zacks Investment Research

Tempus AI Expands Strategic Collaborations to Drive Future Growth - Zacks Investment Research

Matthew Rabinowitz Donates 6,000 Natera Shares to Charity on October 7, 2026 - Kalkine Media

Natera CEO Steven Chapman sells $526k in common stock By Investing.com - Investing.com UK

Natera CEO Steven Chapman sells $526k in common stock - Investing.com

Natera (NTRA) clinical diagnostics president sells 3,000 shares under a trading plan. - Stock Titan

Morgan Stanley Smith Barney is broker for a proposed 1,273-share sale at Natera (NTRA). - Stock Titan

After five sales in three months, a Natera (NTRA) officer proposes another stock sale. - Stock Titan

Form 4 Natera Inc For: 25 September By Investing.com - Investing.com UK

Form 4 Natera Inc For: 25 September By Investing.com - Investing.com Australia

Form 4 Natera Inc For: 25 September By Investing.com - Investing.com Nigeria

Under a preset plan, two trusts sold 18,064 Natera (NTRA) shares in 12 transactions. - Stock Titan

Natera director Sheena’s trusts dispose of $7.0m in NTRA stock - Investing.com

Natera Director Sheena Jonathan to Offload 21,064 Shares Worth $8.16M, Form 144 Filed - Kalkine Media

Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDx - Zacks Investment Research

$8.2M stock sale planned at Natera (NASDAQ: NTRA) - Stock Titan

Natera (NASDAQ: NTRA) co-founder sells 9,150 shares under 10b5-1 plan - Stock Titan

Natera (NASDAQ: NTRA) chair unloads stock in preset plan - Stock Titan

Trust tied to Natera (NASDAQ: NTRA) eyes new stock sale after multimillion-dollar trades - Stock Titan

Understanding Momentum Shifts in (NTRA) - Stock Traders Daily

Did Earnings Beat Just Shift Natera (NTRA) Investment Narrative? - webull.com

Natera(NTRA.US) Officer Sells US$16.4 Million in Common Stock - Moomoo

Ähnlich wie NTRA